393 related articles for article (PubMed ID: 11212266)
1. Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.
Landis DM; Heindel CC; Loeb LA
Cancer Res; 2001 Jan; 61(2):666-72. PubMed ID: 11212266
[TBL] [Abstract][Full Text] [Related]
2. Tolerance of 5-fluorodeoxyuridine resistant human thymidylate synthases to alterations in active site residues.
Landis DM; Gerlach JL; Adman ET; Loeb LA
Nucleic Acids Res; 1999 Sep; 27(18):3702-11. PubMed ID: 10471740
[TBL] [Abstract][Full Text] [Related]
3. Kinetic studies on drug-resistant variants of Escherichia coli thymidylate synthase: functional effects of amino acid substitutions at residue 4.
Mahdavian E; Spencer HT; Dunlap RB
Arch Biochem Biophys; 1999 Aug; 368(2):257-64. PubMed ID: 10441376
[TBL] [Abstract][Full Text] [Related]
4. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
Fantz C; Shaw D; Jennings W; Forsthoefel A; Kitchens M; Phan J; Minor W; Lebioda L; Berger FG; Spencer HT
Mol Pharmacol; 2000 Feb; 57(2):359-66. PubMed ID: 10648646
[TBL] [Abstract][Full Text] [Related]
5. Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
Reilly RT; Barbour KW; Dunlap RB; Berger FG
Mol Pharmacol; 1995 Jul; 48(1):72-9. PubMed ID: 7623777
[TBL] [Abstract][Full Text] [Related]
6. A hydroxyl group at residue 216 is essential for catalysis by human thymidylate synthase.
Williams AW; Dunlap RB; Berger SH
Biochemistry; 1998 May; 37(20):7096-102. PubMed ID: 9585520
[TBL] [Abstract][Full Text] [Related]
7. Functional effects of amino acid substitutions at residue 33 of human thymidylate synthase.
Reilly RT; Forsthoefel AM; Berger FG
Arch Biochem Biophys; 1997 Jun; 342(2):338-43. PubMed ID: 9186496
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
9. Distribution of mutations in human thymidylate synthase yielding resistance to 5-fluorodeoxyuridine.
Kawate H; Landis DM; Loeb LA
J Biol Chem; 2002 Sep; 277(39):36304-11. PubMed ID: 12147691
[TBL] [Abstract][Full Text] [Related]
10. Random sequence mutagenesis and resistance to 5-fluorouridine in human thymidylate synthases.
Landis DM; Loeb LA
J Biol Chem; 1998 Oct; 273(40):25809-17. PubMed ID: 9748254
[TBL] [Abstract][Full Text] [Related]
11. Altered mouse leukemia L1210 thymidylate synthase, associated with cell resistance to 5-fluoro-dUrd, is not mutated but rather reflects posttranslational modification.
Cieśla J; Fraczyk T; Zieliński Z; Sikora J; Rode W
Acta Biochim Pol; 2006; 53(1):189-98. PubMed ID: 16505899
[TBL] [Abstract][Full Text] [Related]
12. Mutants of Chinese hamster cells deficient in thymidylate synthetase.
Li IC; Chu EH
J Cell Physiol; 1984 Aug; 120(2):109-16. PubMed ID: 6611339
[TBL] [Abstract][Full Text] [Related]
13. Genetic complementation and resistance to 5-fluoro-2'-deoxyuridine in thymidine auxotrophs expressing a highly defective mutant of human thymidylate synthase.
Zapf JW; Zhao PS; Steadman DJ; Berger SH
Biochem Pharmacol; 1999 Sep; 58(6):973-81. PubMed ID: 10509749
[TBL] [Abstract][Full Text] [Related]
14. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
Barbour KW; Hoganson DK; Berger SH; Berger FG
Mol Pharmacol; 1992 Aug; 42(2):242-8. PubMed ID: 1355260
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
[TBL] [Abstract][Full Text] [Related]
16. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
Berger SH; Jenh CH; Johnson LF; Berger FG
Mol Pharmacol; 1985 Nov; 28(5):461-7. PubMed ID: 2932632
[TBL] [Abstract][Full Text] [Related]
19. [The association of expression and gene polymorphism of the thymidylate synthase gene with 5-fluoro-5'-deoxyuridine sensitivity in gastric cancer cell lines].
Kaneko M; Kawakami K; Oyama K; Endo Y; Tanaka M; Sasaki T; Watanabe G
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1347-50. PubMed ID: 15446554
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
